Inflammatory Bowel Disease and Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 15 October 2025 | Viewed by 665
Special Issue Editor
Interests: inflammatory bowel disease; ulcerative colitis; Crohn’s disease; advanced therapy; biological drugs; small molecules; non-invasive monitoring; endoscopy; histology; fecal calprotectin
Special Issue Information
Dear Colleagues,
Crohn's disease and ulcerative colitis are difficult-to-treat inflammatory bowel diseases (IBD). Uncontrolled inflammation, long-term disease and the onset of complications such as strictures or fistulas can expose patients with IBD to an increased risk of cancer. In recent decades, several efforts have been made to improve screening programs and develop new drugs and new tools for monitoring patients and reducing the risk of cancer. This Special Issue will focus on the association between IBD and cancer, providing a guidance for clinicians to use advanced therapies, improve patient disease control and prevent complications.
Dr. Ferdinando D'Amico
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- inflammatory bowel disease
- ulcerative colitis
- Crohn’s disease
- cancer
- malignancy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
